As of 2025-07-05, the Intrinsic Value of Molecular Templates Inc (MTEM) is (8,941. USD. This MTEM valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.11 USD, the upside of Molecular Templates Inc is -8341133.4%.

The range of the Intrinsic Value is (28,735.77) - (4,693.98) USD.

Is MTEM undervalued or overvalued?

Based on its market price of 0.11 USD and our intrinsic valuation, Molecular Templates Inc (MTEM) is overvalued by 8341133.4%.

Note: result may not be accurate due to the invalid valuation result of DCF model.

0.11 USD

Stock Price

(8,941. USD

Intrinsic Value

Intrinsic Value Details

MTEM Intrinsic Value - Valuation Summary

	Range	Selected	Upside
a
DCF (Growth Exit 5Y)	(28,735.77) - (4,693.98)	(8,941.59)	-8341133.4%
Peter Lynch Fair Value	-12,726.35 - -12,726.35	-12,726.35	-11871695%
P/E Multiples	(34,870.16) - (68,722.21)	(52,559.76)	-49029727.7%
EV/EBITDA Multiples	(13,349.01) - 8,481.01	(5,256.09)	-4903172.8%

MTEM Intrinsic Value - Peers Comparison

	Range	Selected	Upside
a
Abbvie Inc	59.32 - 370.17	115.65	-38.9%
Amgen Inc	171.06 - 648.77	291.18	-2.4%
Gilead Sciences Inc	17.11 - 104.36	34.41	-69.2%
Regeneron Pharmaceuticals Inc	439.93 - 993.34	599.99	9.6%
Black Diamond Therapeutics Inc	0.45 - 0.45	0.45	-82.6%
Sesen Bio Inc	0.48 - 0.48	0.48	-23.2%

MTEM Intrinsic Value - Key Valuation Metrics

Market Cap (mil)	0
Beta	-313.66
Outstanding shares (mil)	0
Enterprise Value (mil)	-10

Market risk premium	5.1%
Cost of Equity	7.95%
Cost of Debt	11.3%
WACC	9.6%